KR100701012B1 - 다가 어레이 제조 시약 및 방법 및 다가 어레이의 조합라이브러리 - Google Patents
다가 어레이 제조 시약 및 방법 및 다가 어레이의 조합라이브러리 Download PDFInfo
- Publication number
- KR100701012B1 KR100701012B1 KR1020017016230A KR20017016230A KR100701012B1 KR 100701012 B1 KR100701012 B1 KR 100701012B1 KR 1020017016230 A KR1020017016230 A KR 1020017016230A KR 20017016230 A KR20017016230 A KR 20017016230A KR 100701012 B1 KR100701012 B1 KR 100701012B1
- Authority
- KR
- South Korea
- Prior art keywords
- group
- polymer
- functionalized
- capping agent
- multivalent
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 149
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 59
- 238000003491 array Methods 0.000 title claims abstract description 34
- 229920000642 polymer Polymers 0.000 claims abstract description 247
- 125000000524 functional group Chemical group 0.000 claims abstract description 140
- 239000000178 monomer Substances 0.000 claims abstract description 134
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 90
- 239000003054 catalyst Substances 0.000 claims abstract description 68
- 229910052751 metal Inorganic materials 0.000 claims abstract description 58
- 239000002184 metal Substances 0.000 claims abstract description 58
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 claims abstract description 51
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229910052707 ruthenium Inorganic materials 0.000 claims abstract description 24
- 230000000379 polymerizing effect Effects 0.000 claims abstract description 18
- 229920006250 telechelic polymer Polymers 0.000 claims abstract description 12
- 229910052762 osmium Inorganic materials 0.000 claims abstract description 10
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000006243 chemical reaction Methods 0.000 claims description 80
- 125000000962 organic group Chemical group 0.000 claims description 70
- 238000007152 ring opening metathesis polymerisation reaction Methods 0.000 claims description 57
- 239000007787 solid Substances 0.000 claims description 57
- 238000007306 functionalization reaction Methods 0.000 claims description 56
- -1 ketal Chemical compound 0.000 claims description 41
- 239000003446 ligand Substances 0.000 claims description 36
- 150000002148 esters Chemical class 0.000 claims description 33
- 230000008569 process Effects 0.000 claims description 33
- 238000006116 polymerization reaction Methods 0.000 claims description 30
- 150000001336 alkenes Chemical class 0.000 claims description 25
- 229910052739 hydrogen Inorganic materials 0.000 claims description 24
- 239000001257 hydrogen Substances 0.000 claims description 24
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 22
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 20
- 125000005647 linker group Chemical group 0.000 claims description 17
- 238000004519 manufacturing process Methods 0.000 claims description 16
- 239000002253 acid Substances 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 15
- HUGYQXFQBHWMQD-UHFFFAOYSA-N 8-methyl-8-azabicyclo[3.2.1]octan-3-one;hydrochloride Chemical compound Cl.C1C(=O)CC2CCC1N2C HUGYQXFQBHWMQD-UHFFFAOYSA-N 0.000 claims description 14
- 150000001720 carbohydrates Chemical class 0.000 claims description 14
- 150000001412 amines Chemical class 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 13
- 150000001540 azides Chemical class 0.000 claims description 12
- 150000002118 epoxides Chemical class 0.000 claims description 12
- 230000000269 nucleophilic effect Effects 0.000 claims description 12
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims description 11
- 125000006853 reporter group Chemical group 0.000 claims description 10
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims description 9
- 125000000129 anionic group Chemical group 0.000 claims description 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 claims description 8
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 claims description 8
- 239000002738 chelating agent Substances 0.000 claims description 8
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 claims description 8
- 150000002739 metals Chemical class 0.000 claims description 8
- 229930014626 natural product Natural products 0.000 claims description 8
- 125000004122 cyclic group Chemical group 0.000 claims description 7
- 150000007857 hydrazones Chemical class 0.000 claims description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 7
- 150000002576 ketones Chemical class 0.000 claims description 7
- 230000007935 neutral effect Effects 0.000 claims description 7
- 150000001345 alkine derivatives Chemical class 0.000 claims description 6
- 150000004820 halides Chemical class 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 6
- 238000006467 substitution reaction Methods 0.000 claims description 6
- 150000003573 thiols Chemical class 0.000 claims description 6
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 5
- 150000007513 acids Chemical class 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 claims description 5
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims description 4
- 230000003213 activating effect Effects 0.000 claims description 4
- 125000002252 acyl group Chemical group 0.000 claims description 4
- 125000003277 amino group Chemical class 0.000 claims description 4
- 150000008064 anhydrides Chemical class 0.000 claims description 4
- 125000004185 ester group Chemical group 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 125000002015 acyclic group Chemical group 0.000 claims description 3
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 claims description 3
- 150000001735 carboxylic acids Chemical class 0.000 claims description 3
- 150000005675 cyclic monoalkenes Chemical group 0.000 claims description 3
- 239000012948 isocyanate Substances 0.000 claims description 3
- 150000002513 isocyanates Chemical class 0.000 claims description 3
- 150000002923 oximes Chemical class 0.000 claims description 3
- AQSJGOWTSHOLKH-UHFFFAOYSA-N phosphite(3-) Chemical class [O-]P([O-])[O-] AQSJGOWTSHOLKH-UHFFFAOYSA-N 0.000 claims description 3
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 claims description 3
- 238000011084 recovery Methods 0.000 claims description 3
- 229940124530 sulfonamide Drugs 0.000 claims description 3
- 150000003457 sulfones Chemical class 0.000 claims description 3
- 230000002194 synthesizing effect Effects 0.000 claims description 3
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical class C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 claims description 2
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 claims description 2
- 150000002429 hydrazines Chemical class 0.000 claims description 2
- 238000007142 ring opening reaction Methods 0.000 claims description 2
- 150000003567 thiocyanates Chemical class 0.000 claims description 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 3
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 150000001450 anions Chemical class 0.000 claims 1
- 210000001217 buttock Anatomy 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 150000002540 isothiocyanates Chemical class 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 69
- 239000000243 solution Substances 0.000 description 47
- 239000000463 material Substances 0.000 description 45
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 41
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 32
- 210000004027 cell Anatomy 0.000 description 27
- 238000003786 synthesis reaction Methods 0.000 description 22
- 230000015572 biosynthetic process Effects 0.000 description 21
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 20
- 239000002904 solvent Substances 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 235000019439 ethyl acetate Nutrition 0.000 description 15
- 230000027455 binding Effects 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 11
- 125000003118 aryl group Chemical group 0.000 description 11
- 238000010168 coupling process Methods 0.000 description 11
- 239000003999 initiator Substances 0.000 description 11
- 229910052757 nitrogen Inorganic materials 0.000 description 11
- 239000011734 sodium Substances 0.000 description 11
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 125000001931 aliphatic group Chemical group 0.000 description 10
- XJWSAJYUBXQQDR-UHFFFAOYSA-M dodecyltrimethylammonium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)C XJWSAJYUBXQQDR-UHFFFAOYSA-M 0.000 description 10
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 10
- 229920005989 resin Polymers 0.000 description 10
- 239000011347 resin Substances 0.000 description 10
- 108010092694 L-Selectin Proteins 0.000 description 9
- 102000016551 L-selectin Human genes 0.000 description 9
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 9
- 150000002430 hydrocarbons Chemical class 0.000 description 9
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 description 9
- 238000004809 thin layer chromatography Methods 0.000 description 9
- 229920001400 block copolymer Polymers 0.000 description 8
- 235000014633 carbohydrates Nutrition 0.000 description 8
- 238000005859 coupling reaction Methods 0.000 description 8
- 229920002521 macromolecule Polymers 0.000 description 8
- 230000004048 modification Effects 0.000 description 8
- 238000012986 modification Methods 0.000 description 8
- 229920005604 random copolymer Polymers 0.000 description 8
- 102000000844 Cell Surface Receptors Human genes 0.000 description 7
- 108010001857 Cell Surface Receptors Proteins 0.000 description 7
- 238000003556 assay Methods 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 230000008878 coupling Effects 0.000 description 7
- 238000003818 flash chromatography Methods 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 6
- 108010062580 Concanavalin A Proteins 0.000 description 6
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 6
- 150000001299 aldehydes Chemical group 0.000 description 6
- 150000001408 amides Chemical class 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 238000005227 gel permeation chromatography Methods 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 5
- JCPUGBBSZRZZNM-UHFFFAOYSA-N 2-[2-(2-phenylmethoxyethoxy)ethoxy]acetic acid Chemical compound OC(=O)COCCOCCOCC1=CC=CC=C1 JCPUGBBSZRZZNM-UHFFFAOYSA-N 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 238000007720 emulsion polymerization reaction Methods 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- WZMDHLKWWLPXIT-DCQXENGUSA-N (2s,3s,4r,5s)-1,2,3,4,5-pentahydroxy-6-oxohexane-1,4-disulfonic acid Chemical class O=C[C@H](O)[C@](O)(S(O)(=O)=O)[C@@H](O)[C@H](O)C(O)S(O)(=O)=O WZMDHLKWWLPXIT-DCQXENGUSA-N 0.000 description 4
- BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 4
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 229910019443 NaSi Inorganic materials 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000012298 atmosphere Substances 0.000 description 4
- 230000001588 bifunctional effect Effects 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 4
- 229910052794 bromium Inorganic materials 0.000 description 4
- 238000005277 cation exchange chromatography Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- BGRWYRAHAFMIBJ-UHFFFAOYSA-N diisopropylcarbodiimide Natural products CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 238000010348 incorporation Methods 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 150000003568 thioethers Chemical class 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- YZUPZGFPHUVJKC-UHFFFAOYSA-N 1-bromo-2-methoxyethane Chemical compound COCCBr YZUPZGFPHUVJKC-UHFFFAOYSA-N 0.000 description 3
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000001241 acetals Chemical class 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 150000002084 enol ethers Chemical class 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 238000007429 general method Methods 0.000 description 3
- 230000035931 haemagglutination Effects 0.000 description 3
- 150000003949 imides Chemical class 0.000 description 3
- 125000002524 organometallic group Chemical group 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- GVJXGCIPWAVXJP-UHFFFAOYSA-N 2,5-dioxo-1-oxoniopyrrolidine-3-sulfonate Chemical compound ON1C(=O)CC(S(O)(=O)=O)C1=O GVJXGCIPWAVXJP-UHFFFAOYSA-N 0.000 description 2
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 2
- WULYHVICHJATHH-UHFFFAOYSA-N 2-trimethylsilylethyl 2-[2-(2-phenylmethoxyethoxy)ethoxy]acetate Chemical compound C[Si](C)(C)CCOC(=O)COCCOCCOCC1=CC=CC=C1 WULYHVICHJATHH-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 229930182816 L-glutamine Natural products 0.000 description 2
- 102000018697 Membrane Proteins Human genes 0.000 description 2
- 108010052285 Membrane Proteins Proteins 0.000 description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical class ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 150000001266 acyl halides Chemical class 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 125000003158 alcohol group Chemical group 0.000 description 2
- 125000002723 alicyclic group Chemical group 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- 125000002619 bicyclic group Chemical group 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000013626 chemical specie Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 229940125898 compound 5 Drugs 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 238000010550 living polymerization reaction Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- HOVAGTYPODGVJG-VEIUFWFVSA-N methyl alpha-D-mannoside Chemical compound CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O HOVAGTYPODGVJG-VEIUFWFVSA-N 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 239000011733 molybdenum Substances 0.000 description 2
- OKDQKPLMQBXTNH-UHFFFAOYSA-N n,n-dimethyl-2h-pyridin-1-amine Chemical compound CN(C)N1CC=CC=C1 OKDQKPLMQBXTNH-UHFFFAOYSA-N 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 125000000538 pentafluorophenyl group Chemical group FC1=C(F)C(F)=C(*)C(F)=C1F 0.000 description 2
- 150000003014 phosphoric acid esters Chemical class 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000012987 post-synthetic modification Methods 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 229930195734 saturated hydrocarbon Natural products 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 238000001542 size-exclusion chromatography Methods 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 229940054269 sodium pyruvate Drugs 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 238000003746 solid phase reaction Methods 0.000 description 2
- 238000010671 solid-state reaction Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 150000005691 triesters Chemical class 0.000 description 2
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- ONDSBJMLAHVLMI-UHFFFAOYSA-N trimethylsilyldiazomethane Chemical compound C[Si](C)(C)[CH-][N+]#N ONDSBJMLAHVLMI-UHFFFAOYSA-N 0.000 description 2
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- 0 *C=CCOCCOCC(OCCN)=O Chemical compound *C=CCOCCOCC(OCCN)=O 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- HBOMLICNUCNMMY-KJFJCRTCSA-N 1-[(4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-KJFJCRTCSA-N 0.000 description 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- AGCPPSNKHQEFRX-UHFFFAOYSA-N 1-azidoethanol Chemical compound CC(O)N=[N+]=[N-] AGCPPSNKHQEFRX-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- CHKNUEONKKGVAJ-UHFFFAOYSA-N 2-[[bis(2-hydroxyethyl)amino]methyl]propane-1,2,3-triol Chemical compound OCCN(CCO)CC(O)(CO)CO CHKNUEONKKGVAJ-UHFFFAOYSA-N 0.000 description 1
- ZNGINKJHQQQORD-UHFFFAOYSA-N 2-trimethylsilylethanol Chemical compound C[Si](C)(C)CCO ZNGINKJHQQQORD-UHFFFAOYSA-N 0.000 description 1
- WYEONKPPWKAIQG-UHFFFAOYSA-N 3,3-bis(trimethylsilyl)propanoic acid Chemical group C[Si](C)(C)C([Si](C)(C)C)CC(O)=O WYEONKPPWKAIQG-UHFFFAOYSA-N 0.000 description 1
- AFPHTEQTJZKQAQ-UHFFFAOYSA-N 3-nitrobenzoic acid Chemical compound OC(=O)C1=CC=CC([N+]([O-])=O)=C1 AFPHTEQTJZKQAQ-UHFFFAOYSA-N 0.000 description 1
- CSDQQAQKBAQLLE-UHFFFAOYSA-N 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1=CC(Cl)=CC=C1C1C(C=CS2)=C2CCN1 CSDQQAQKBAQLLE-UHFFFAOYSA-N 0.000 description 1
- MNHKUCBXXMFQDM-UHFFFAOYSA-N 4-[(4-nitrophenyl)methyl]pyridine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CC1=CC=NC=C1 MNHKUCBXXMFQDM-UHFFFAOYSA-N 0.000 description 1
- BZPBTUJGQVANMU-UHFFFAOYSA-N 5-methoxypent-4-enoic acid Chemical compound COC=CCCC(O)=O BZPBTUJGQVANMU-UHFFFAOYSA-N 0.000 description 1
- RBRGWYHSVYKUQT-UHFFFAOYSA-N 5-oxabicyclo[2.2.1]hept-2-ene Chemical compound C1C2COC1C=C2 RBRGWYHSVYKUQT-UHFFFAOYSA-N 0.000 description 1
- COEDAHBOYNENAX-UHFFFAOYSA-N 7-thiabicyclo[2.2.1]hept-2-ene Chemical compound S1C2CCC1C=C2 COEDAHBOYNENAX-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 101100301148 Arabidopsis thaliana RCCR gene Proteins 0.000 description 1
- 108010031480 Artificial Receptors Proteins 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- MNYPBMIZZXOTPO-UHFFFAOYSA-N COCCOCCOCCOCc1ccccc1 Chemical compound COCCOCCOCCOCc1ccccc1 MNYPBMIZZXOTPO-UHFFFAOYSA-N 0.000 description 1
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
- 240000006162 Chenopodium quinoa Species 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 102400001368 Epidermal growth factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 239000007821 HATU Substances 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 101000687448 Homo sapiens REST corepressor 1 Proteins 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 241001274216 Naso Species 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 208000009052 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- 102100024864 REST corepressor 1 Human genes 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 208000029052 T-cell acute lymphoblastic leukemia Diseases 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical group C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- 201000011186 acute T cell leukemia Diseases 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010539 anionic addition polymerization reaction Methods 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
- RBFQJDQYXXHULB-UHFFFAOYSA-N arsane Chemical compound [AsH3] RBFQJDQYXXHULB-UHFFFAOYSA-N 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- GACSFNQTERQWMN-UHFFFAOYSA-N benzyl 5-methoxypent-4-enoate Chemical compound COC=CCCC(=O)OCC1=CC=CC=C1 GACSFNQTERQWMN-UHFFFAOYSA-N 0.000 description 1
- XHZWDEGVEUATPY-UHFFFAOYSA-N benzyl pent-4-enoate Chemical compound C=CCCC(=O)OCC1=CC=CC=C1 XHZWDEGVEUATPY-UHFFFAOYSA-N 0.000 description 1
- PNPBGYBHLCEVMK-UHFFFAOYSA-L benzylidene(dichloro)ruthenium;tricyclohexylphosphane Chemical compound Cl[Ru](Cl)=CC1=CC=CC=C1.C1CCCCC1P(C1CCCCC1)C1CCCCC1.C1CCCCC1P(C1CCCCC1)C1CCCCC1 PNPBGYBHLCEVMK-UHFFFAOYSA-L 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 238000010538 cationic polymerization reaction Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000015861 cell surface binding Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229940117975 chromium trioxide Drugs 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N chromium trioxide Inorganic materials O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- GAMDZJFZMJECOS-UHFFFAOYSA-N chromium(6+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Cr+6] GAMDZJFZMJECOS-UHFFFAOYSA-N 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- CFBGXYDUODCMNS-UHFFFAOYSA-N cyclobutene Chemical compound C1CC=C1 CFBGXYDUODCMNS-UHFFFAOYSA-N 0.000 description 1
- URYYVOIYTNXXBN-UPHRSURJSA-N cyclooctene Chemical compound C1CCC\C=C/CC1 URYYVOIYTNXXBN-UPHRSURJSA-N 0.000 description 1
- 239000004913 cyclooctene Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 229920000736 dendritic polymer Polymers 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000006471 dimerization reaction Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 150000002500 ions Chemical group 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- SJFNDMHZXCUXSA-UHFFFAOYSA-M methoxymethyl(triphenyl)phosphanium;chloride Chemical compound [Cl-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(COC)C1=CC=CC=C1 SJFNDMHZXCUXSA-UHFFFAOYSA-M 0.000 description 1
- RIJWDPRXCXJDPK-UHFFFAOYSA-N methyl 3-cyclopropyl-3-oxopropanoate Chemical compound COC(=O)CC(=O)C1CC1 RIJWDPRXCXJDPK-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 150000005673 monoalkenes Chemical class 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 125000004971 nitroalkyl group Chemical group 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 125000003518 norbornenyl group Chemical group C12(C=CC(CC1)C2)* 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 238000002161 passivation Methods 0.000 description 1
- HVAMZGADVCBITI-UHFFFAOYSA-N pent-4-enoic acid Chemical compound OC(=O)CCC=C HVAMZGADVCBITI-UHFFFAOYSA-N 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920013716 polyethylene resin Polymers 0.000 description 1
- 239000002685 polymerization catalyst Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 150000003141 primary amines Chemical group 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000002407 reforming Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 125000004964 sulfoalkyl group Chemical group 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 150000007944 thiolates Chemical class 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 102000027257 transmembrane receptors Human genes 0.000 description 1
- 108091008578 transmembrane receptors Proteins 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2265—Carbenes or carbynes, i.e.(image)
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/165—Polymer immobilised coordination complexes, e.g. organometallic complexes
- B01J31/1658—Polymer immobilised coordination complexes, e.g. organometallic complexes immobilised by covalent linkages, i.e. pendant complexes with optional linking groups, e.g. on Wang or Merrifield resins
- B01J31/1666—Polymer immobilised coordination complexes, e.g. organometallic complexes immobilised by covalent linkages, i.e. pendant complexes with optional linking groups, e.g. on Wang or Merrifield resins the linkage established via an olefin metathesis reaction
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/002—Osmium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0046—Ruthenium compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F10/00—Homopolymers and copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/005—Beads
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00585—Parallel processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00596—Solid-phase processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/0061—The surface being organic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00623—Immobilisation or binding
- B01J2219/00626—Covalent
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00722—Nucleotides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00738—Organic catalysts
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/10—Polymerisation reactions involving at least dual use catalysts, e.g. for both oligomerisation and polymerisation
- B01J2231/14—Other (co) polymerisation, e.g. of lactides, epoxides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/821—Ruthenium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/825—Osmium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/11—Compounds covalently bound to a solid support
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/14—Libraries containing macromolecular compounds and not covered by groups C40B40/06 - C40B40/12
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
그러한 다가 어레이는 의약 및 생명공학 분야에서 특히 유용하다. 예컨대, 세포 표면 수용체를 다가 어레이의 특정 에피토프에 결합하는 것은 넓고 다양한 생물학적 반응을 일으킬 수 있다. 그러한 다가 결합은 1가 상호작용에 의해 도출된 것과 완전히 다른 특유한 결과를 가져온다. 예컨대, 표피성장인자를 통한 신호는 막횡단 수용체의 2량체화를 명백히 촉진시키는 2가 리간드의 결합에 의해 촉진되지만, 1가 리간드는 수용체를 결합시키지만 신호를 생성하지 않는다. 게다가, 다가 어레이는 세포 표면 단백질의 유리를 일으키는 것으로 나타났으며, 단백질 디스플레이를 조절하는 새로운 메커니즘을 제시한다. 단백질-탄수화물 인식 과정에 있어서, 다가 사카라이드-치환 어레이는 전단흐름(shear flow)의 동적 조건 하에서 증가된 친화력, 특이성 및 특유한 저해 효능을 나타낼 수 있다. 따라서 생물학적으로 관련된 결합 에피토프의 정의된 다가 어레이를 합성하는 능력은 생리학적으로 중요한 과정을 탐색하고 다루는 수단을 제공한다.
Claims (93)
- 텔레켈릭 중합체의 제조 방법에 있어서,하나 이상의 루테늄 또는 오스뮴 카르벤 촉매의 존재 하에 개환 치환 중합( ROMP)를 통해 중합된 하나 이상의 중합성 기를 포함하는 하나 이상의 단량체를 중합하여 중합체를 형성시키는 단계; 및중합체를 캡핑제와 반응시키기에 유효한 조건 하에 중합체를 하나 이상의 캡핑제와 결합시키는 단계로서, 카르벤 촉매, 캡핑제 또는 양자 모두 관능화되어 말단 관능화 중합체를 형성시키는 단계;를 포함하는 방법.
- 제 1 항에 있어서, 관능화 캡핑제가 관능화 시약과 연속 반응하기 위해 잠재적 반응기를 포함하는 것을 특징으로 하는 방법.
- 제 1 항에 있어서, 관능화 캡핑제가 비반응 관능기를 포함하는 것을 특징으로 하는 방법.
- 제 1 항에 있어서, 중합체가 모노텔레켈릭 중합체인 것을 특징으로 하는 방법.
- 제 1 항에 있어서, 루테늄 또는 오스뮴 카르벤 촉매가 관능화된 것을 특징으로 하는 방법.
- 제 7 항에 있어서, 관능화 카르벤 촉매가 관능화 시약과 연속 반응하기 위해 잠재적 반응기를 포함하는 것을 특징으로 하는 방법.
- 제 8 항에 있어서, 관능화 카르벤이 M=CR4R5 (식중, R4 은 잠재적 반응기를 포함하는 유기기이고, R5 는 H 또는 유기기이고, M 은 리간드 구에서 루테늄 또는 오스뮴이다) 으로 표현된 것을 특징으로 하는 방법.
- 제 9 항에 있어서, R4 은 아지드, 에폭시드, 시아노기, 아세탈, 케탈, 카르바메이트, 티오시아네이트, 활성화 에스테르, 활성산, 히드라진 및 히드라존의 군으로부터 선택된 잠재적 반응기를 포함하는 것을 특징으로 하는 방법.
- 제 7 항에 있어서, 관능화 카르벤 촉매가 비반응 관능기를 포함하는 것을 특징으로 하는 방법.
- 제 12 항에 있어서, 관능화 카르벤이 M=CR4R5 (식중, R4 은 비반응 관능기를 포함하는 유기기이고, R5 는 H 또는 유기기이고, M 은 리간드 구에서 루테늄 또는 오스뮴이다) 으로 표현된 것을 특징으로 하는 방법.
- 제 13 항에 있어서, R4 는 천연 생성물 또는 그의 유사체, 금속 킬레이터, 금속들, 형광 시료, 고체 지지체 및 금속 표면으로부터 선택된 비반응 관능기를 포함하는 유기기인 것을 특징으로 하는 방법.
- 제 7 항에 있어서, 중합체가 모노텔레켈릭 중합체인 것을 특징으로 하는 방법.
- 제 1 항에 있어서, 중합체가 이텔레켈릭 중합체인 것을 특징으로 하는 방법.
- 제 17 항에 있어서, 관능화 캡핑제가 관능화 시약과 연속 반응하기 위해 잠재적 반응기를 포함하는 것을 특징으로 하는 방법.
- 제 17 항에 있어서, 관능화 캡핑제가 비반응 관능기를 포함하는 것을 특징으로 하는 방법.
- 제 17 항에 있어서, 관능화 카르벤 촉매가 관능화 시약과 연속 반응하기 위해 잠재적 반응기를 포함하는 것을 특징으로 하는 방법.
- 제 20 항에 있어서, 관능화 카르벤이 M=CR4R5 (식중, R4 은 잠재적 반응기를 포함하는 유기기이고, R5 는 H 또는 유기기이고, M 은 리간드 구에서 루테늄 또는 오스뮴이다) 으로 표현된 것을 특징으로 하는 방법.
- 제 21 항에 있어서, R4 은 아지드, 에폭시드, 시아노기, 아세탈, 케탈, 카르바메이트, 티오시아네이트, 활성화 에스테르, 활성산, 히드라진 및 히드라존의 군으로부터 선택된 잠재적 반응기를 포함하는 것을 특징으로 하는 방법.
- 제 1 항에 있어서, 관능화 캡핑제가 분할가능한 연결기를 포함하는 것을 특징으로 하는 방법.
- 제 23 항에 있어서, 캡핑제가 비반응 관능기를 포함하는 것을 특징으로 하는 방법.
- 제 24 항에 있어서, 비반응 관능기가 고체 지지체인 것을 특징으로 하는 방법.
- 제 26 항에 있어서, W 는 NO2 기이고, Z 는 OR 기 (이때 R 은 알킬 부분이다) 인 것을 특징으로 하는 방법.
- 제 1 항에 있어서, 관능화 금속 카르벤 촉매가 비반응 관능기를 포함하는 것을 특징으로 하는 방법.
- 제 28 항에 있어서, 비반응 관능기가 고체 지지체인 것을 특징으로 하는 방법.
- 제 32 항에 있어서, LK 는 식 -(M)m-LK1-(N)p-LK2 (식중, M 및 N 은 동일하거나 상이한 유기기이고 ; m 및 p 는 0 내지 약 20 의 범위인 정수이고 LK1 및 LK2 는 관능기이다) 를 갖는 것을 특징으로 하는 캡핑제.
- 제 33 항에 있어서, LK1 이 분할가능한 관능기인 것을 특징으로 하는 캡핑제.
- 다가 어레이의 제조 방법에 있어서, 하기를 포함하는 방법 :금속 카르벤 촉매의 존재하에 하나 이상의 중합성기 및 하나 이상의 잠재적 반응기를 포함하는 하나 이상의 단량체를 중합하여 하나 이상의 잠재적 반응기를 포함하는 중합체 주형을 생성하고 ;유효한 조건하에 하나 이상의 반응기를 포함하는 하나 이상의 관능화 시약과 중합체 주형을 조합하여 관능화 시약의 반응기와 중합체 주형의 잠재적 반응기를 반응시켜 다가 어레이를 생성하는 방법.
- 제 37 항에 있어서, 단량체가 단지 하나의 중합성기인 것을 특징으로 하는 방법.
- 제 38 항에 있어서, 단량체가 시클릭 모노-올레핀인 것을 특징으로 하는 방법.
- 제 39 항에 있어서, 시클릭 모노-올레핀이 비시클릭 화합물인 것을 특징으로 하는 방법.
- 제 37 항에 있어서, 단량체가 관능화 시약의 반응기를 갖는 비반응 관능기를 더 포함하는 것을 특징으로 하는 방법.
- 제 37 항에 있어서, 단량체의 잠재적 반응기가 친핵성기를 포함하고 관능화 시약의 반응기가 친전자성 기를 포함하는 것을 특징으로 하는 방법.
- 제 37 항에 있어서, 단량체의 잠재적 반응기가 친전자성 기를 포함하고 관능화 시약의 반응기가 친핵성 기를 포함하는 것을 특징으로 하는 방법.
- 제 43 항에 있어서, 친핵성기가 아민, 아지드, 히드록실, 티올, 술폰, 아실 히드라지드, 니트로기, 포스파이트, 히드라진, 옥심, 이소시아네이트, 히드록삼산, 및 티오시아네이트의 군으로부터 선택된 것을 특징으로 하는 방법.
- 제 43 항에 있어서, 친전자성 기가 아실 술폰아미드, 아실 아지드, 에폭시드, 무수물, 에스테르, 카르복실산, 할라이드, 브롬산 및 에스테르, 케톤, 알데히드, 인산 에스테르, 포스파이트, 아실 니트릴, 알켄, 및 알킨의 군으로부터 선택된 것을 특징으로 하는 방법.
- 제 43 항에 있어서, 친전자성 기는 활성화 에스테르 기이고 친핵성기는 1 차 아민기인 것을 특징으로 하는 방법.
- 제 47 항에 있어서, 단량체가 비시클로[2.2.1]헵트-5-엔-엑소-2-카르복실산 N-히드록시숙신이미드 에스테르인 것을 특징으로 하는 방법.
- 제 337항에 있어서, 금속 카르벤 촉매의 존재하에 둘 이상의 상이한 단량체를 연속적으로 중합하여 상이한 단량체의 블럭을 수정하는 것을 포함하는 중합체 주형을 생성하는 것을 포함하는 것을 특징으로 하는 하나 이상의 단량체를 중합하는 방법.
- 제 49 항에 있어서, 각 상이한 단량체가 펜던트 관능기를 연속적으로 부착하기 위해 상이한 잠재적 반응기를 포함하는 것을 특징으로 하는 방법.
- 제 50 항에 있어서, 하나 이상의 단량체가 추가의 관능화가 필요없는 비반응 펜던트 관능기를 포함하는 것을 특징으로 하는 방법.
- 제 37 항에 있어서, 둘 이상의 상이한 단량체를 동시에 중합하는 것을 포함하는 하나 이상의 단량체를 중합하는 것을 특징으로 하는 방법.
- 제 37 항에 있어서, 다가 어레이를 시약과 반응시켜 어레이중 중합체 주쇄 알켄 결합을 관능화하는 것을 더 포함하는 것을 특징으로 하는 방법.
- 제 37 항에 있어서, 중합체 주형의 잠재적 반응기와 반응하는 관능화 시약이 카르보히드레이트 또는 펩티드를 포함하는 것을 특징으로 하는 방법.
- 제 37 항에 있어서, 실온에서 유기 용매내에 단량체를 중합하는 것을 특징으로 하는 방법.
- 제 37 항에 있어서, 관능화 시약과 조합하기에 앞서 중합체 주형을 캡핑제와 조합하여 중합체 주형의 말단과 반응시키는 것을 더 포함하는 것을 특징으로 하는 방법.
- 제 56 항에 있어서, 캡핑제가 전자가 풍부한 알켄인 것을 특징으로 하는 방법.
- 제 57 항에 있어서, 전자가 풍부한 알켄이 탐색을 용이하게 하는 리포터기를 포함하는 것을 특징으로 하는 방법.
- 제 58 항에 있어서, 전자가 풍부한 알켄이 고체 지지체 또는 금속 표면에 연결할 수 있거나 연결하는 것을 특징으로 하는 방법.
- 제 37 항에 있어서, 중합체 주형을 화학양론 양 미만의 제 1 관능화 시약과 조합하는 것을 포함하는 하나 이상의 관능화 시약과 중합체 주형을 조합하는 것을 특징으로 하는 방법.
- 제 60 항에 있어서, 중합체 주형을 화학양론 양 미만의 제 2 관능화 시약과 조합하는 것을 특징으로 하는 방법.
- 제 62 항에 있어서, n 이 2 이상인 것을 특징으로 하는 중합체 주형.
- 제 62 항에 있어서, 하나 이상의 R4, R5, R6, 및 R7 은 관능기를 포함하는 것을 특징으로 하는 중합체 주형.
- 하기 구조를 갖는 중합체 주형 :(식중, "BB" 는 주쇄 반복 단위를 나타내고, 이는 시클릭 또는 아시클릭일 수 있고, 랜덤 또는 블럭 배열에서 동일하거나 또는 상이할 수 있고, R1 및 R2 는 각각 독립적으로 H 또는 유기기이고, 이는 이들이 고리를 형성하도록 연결될 수 있고, 단 하나 이상의 R1 및 R2 는 보호된 아민 또는 활성화 에스테르를 포함하고, R4, R5, R6 및 R7 은 H 또는 유기기이고, Z 는 독립적으로 수소, 할라이드, 히드록실, 티올, 또는 아민이고, n 은 반복 단량체 단위의 분할가능한 수이다).
- 제 65 항에 있어서, 하나 이상의 R4, R5, R6, 및 R7 은 관능기를 포함하는 것을 특징으로 하는 중합체 주형.
- 제 65 항의 중합체 주형 및 펜던트 관능기를 중합체 주형에 부착하기 위해 관능화 시약을 이용하기 위한 지시 수단을 포함하는 키트.
- 제 67 항에 있어서, 하나 이상의 관능화 시약을 더 포함하는 것을 특징으로 하는 키트.
- 제 68 항에 있어서, 하나 이상의 캡핑제를 더 포함하는 것을 특징으로 하는 키트.
- 제 69 항에 있어서, 캡핑제가 관능화된 것을 특징으로 하는 키트.
- 제 69 항에 있어서, 캡핑제가 전자가 풍부한 알켄인 것을 특징으로 하는 키트.
- 제 71 항에 있어서, 전자가 풍부한 알켄은 탐색을 용이하게 하는 리포터기를 포함하는 것을 특징으로 하는 키트.
- 제 67 항에 있어서, 하나 이상의 관능화 시약을 더 포함하는 것을 특징으로 하는 키트.
- 제 73 항에 있어서, 하나 이상의 캡핑제를 더 포함하는 것을 특징으로 하는 키트.
- 다가 어레이가, 각 단량체 반복 단위가 동일하거나 상이할 수 있는 복수의 단량체 단위를 포함하는 중합체이고, 상기 중합체에서 단량체의 한 부분이 관능기를 포함하고 라이브러리의 각 다가 어레이가 정의된 길이 및 정의된 관능화 기 밀도를 갖는 것을 특징으로 하는, 복수의 다가 어레이를 포함하는 라이브러리.
- 제 75 항에 있어서, 다가 어레이의 중합체가 둘이상의 상이한 단량체를 포함하는 것을 특징으로 하는 라이브러리.
- 제 76 항에 있어서, 상이한 단량체가 상이한 관능기를 담지하는 것을 특징으로 하는 라이브러리.
- 제 75 항에 있어서, 동일한 관능기를 담지하는 단량체 사이의 거리가 획정된 것을 특징으로 하는 라이브러리.
- 제 75 항에 있어서, 상이한 관능기를 담지하는 단량체 사이의 공간이 정의된 것을 특징으로 하는 라이브러리.
- 제 75 항에 있어서, 라이브러리의 다가 어레이가 실질적으로 동일한 길이지만, 상이한 관능기 밀도를 가지도록 합성하는 것을 특징으로 하는 라이브러리.
- 제 75 항에 있어서, 라이브러리의 다가 어레이가 실질적으로 상이한 길이를 가지지만, 실질적으로 동일한 관능기 밀도를 가지도록 합성하는 것을 특징으로 하는 라이브러리.
- 제 75 항에 있어서, 라이브러리의 다가 어레이가 동일한 관능기를 담지하는 것을 특징으로 하는 라이브러리.
- 제 75 항에 있어서, 라이브러리의 다가 어레이가 상이한 관능기를 담지하는 것을 특징으로 하는 라이브러리.
- 제 75 항에 있어서, 관능기가 생물학적 활성 관능기인 것을 특징으로 하는 라이브러리.
- 제 75 항에 있어서, 라이브러리의 다가 어레이가 고체에 연결되는 것을 특징으로 하는 라이브러리.
- 제 75 항에 있어서, 다가 어레이가 모노텔레켈릭 중합체인 것을 특징으로 하는 라이브러리.
- 제 75 항에 있어서, 다가 어레이가 이텔레켈릭 중합체인 것을 특징으로 하는 라이브러리.
- 각각의 다가 어레이가 제 1 항의 방법에 의해 제조되는 것을 특징으로 하는, 복수의 다가 어레이를 포함하는 라이브러리.
- 각각의 다가 어레이가 제 37 항의 방법에 의해 제조되는 것을 특징으로 하는, 복수의 다가 어레이를 포함하는 라이브러리.
- (a) 제1항의 방법에 의해 각각의 다가 어레이를 합성하는 단계; 및(b) 상기 다가 어레이를 결합하여 라이브러리를 생성시키는 단계;를 포함하는, 복수의 다가 어레이를 포함하는 라이브러리를 생성시키는 방법.
- 제36항에 있어서, LK는 알킬기와 다른 유기기인 고체-지지 관능화 카르벤.
- 제91항에 있어서, LK는 식 -(M)m-LK1-(N)p-LK2를 가지며, 여기서 M 및 N은 알킬기와 다른, 동일하거나 상이한 유기기이고, m 및 p는 0 내지 20 범위의 정수이며, LK1 및 LK2는 관능기로서 LK1은 잠재적 반응기이고 LK2는 고체에 연결시키는 관능성을 함유하는 고체-지지 관능화 카르벤.
- 제92항에 있어서, LK2는 티올, 및 활성화된 에스테르 또는 아민기이고, LK1은 -O-, -S-, -CO-, -COO-, CO-NR"-이며, 여기서 R"는 수소 또는 유기기인 고체-지지 관능화 카르벤.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/336,121 | 1999-06-17 | ||
US09/335,430 | 1999-06-17 | ||
US09/336,121 US6291616B1 (en) | 1999-06-17 | 1999-06-17 | Methods and reagents for capping ruthenium or osmium carbene-catalyzed ROMP products |
US09/335,430 US6271315B1 (en) | 1999-06-17 | 1999-06-17 | Methods for making multivalent arrays |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020013585A KR20020013585A (ko) | 2002-02-20 |
KR100701012B1 true KR100701012B1 (ko) | 2007-03-29 |
Family
ID=26989698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020017016230A KR100701012B1 (ko) | 1999-06-17 | 2000-06-19 | 다가 어레이 제조 시약 및 방법 및 다가 어레이의 조합라이브러리 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1200484B1 (ko) |
JP (3) | JP2003502488A (ko) |
KR (1) | KR100701012B1 (ko) |
AT (1) | ATE527298T1 (ko) |
AU (1) | AU774036B2 (ko) |
CA (1) | CA2375248C (ko) |
IL (2) | IL147011A0 (ko) |
MX (1) | MXPA01012960A (ko) |
WO (1) | WO2000078821A1 (ko) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003502488A (ja) * | 1999-06-17 | 2003-01-21 | ウィスコンシン・アラムナイ・リサーチ・ファウンデイション | 多価アレイおよび多価アレイのコンビナトリアルライブラリーを作製する方法および試薬 |
DE10105711B4 (de) * | 2001-02-08 | 2005-03-10 | Ibidi Gmbh | Probenträger für chemische und biologische Proben |
AT411760B (de) * | 2002-09-09 | 2004-05-25 | Michael Rudolf Mag Buchmeiser | Verfahren zur herstellung heterogener metathesekatalysatoren durch träger-fixierung |
FR2871803B1 (fr) * | 2004-06-21 | 2007-05-11 | Centre Nat Rech Scient Cnrse | Particules polymeres stimulables presentant des fonctions reactives, leur procede d'obtention, et leurs utilisations |
AU2007226348A1 (en) * | 2006-03-10 | 2007-09-20 | Warwick Effect Polymers Ltd. | Polymers |
GB0604911D0 (en) * | 2006-03-10 | 2006-04-19 | Warwick Effect Polymers Ltd | Polymers |
US7807140B2 (en) * | 2006-05-03 | 2010-10-05 | Wisconsin Alumni Research Foundation | Magnetic resonance imaging contrast agents synthesized using ring-opening metathesis polymerization |
WO2009022477A1 (ja) * | 2007-08-10 | 2009-02-19 | Nihon University | 生理活性物質を結合したノルボルネン系高分子重合体、その製法及び用途 |
TR201909167T4 (tr) * | 2011-01-04 | 2019-07-22 | Gatt Tech B V | Elektrofilik olarak aktive edilmiş polioksazolinden derive edilen çapraz bağlı polimerler ve implantlar. |
AU2014320410A1 (en) | 2013-09-11 | 2016-03-24 | Danmarks Tekniske Universitet | A photolabile linker for the solid-phase synthesis of hydrazides and pyranopyrazoles |
WO2016129600A1 (ja) * | 2015-02-09 | 2016-08-18 | 旭硝子株式会社 | 含フッ素重合体の製造方法 |
GB201611849D0 (en) * | 2016-07-07 | 2016-08-24 | Univ Of Nottingham The | Sulfated glycopolymers |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5880231A (en) * | 1992-04-03 | 1999-03-09 | California Institute Of Technology | Synthesis of telechelic polymers using ruthenium and osmium carbene complexes |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0892357A (ja) * | 1994-09-27 | 1996-04-09 | Nippon Zeon Co Ltd | 変性ノルボルネン系樹脂の製造方法 |
US6080826A (en) * | 1997-01-06 | 2000-06-27 | California Institute Of Technology | Template-directed ring-closing metathesis and ring-opening metathesis polymerization of functionalized dienes |
JP2003502488A (ja) * | 1999-06-17 | 2003-01-21 | ウィスコンシン・アラムナイ・リサーチ・ファウンデイション | 多価アレイおよび多価アレイのコンビナトリアルライブラリーを作製する方法および試薬 |
-
2000
- 2000-06-19 JP JP2001505578A patent/JP2003502488A/ja not_active Withdrawn
- 2000-06-19 MX MXPA01012960A patent/MXPA01012960A/es active IP Right Grant
- 2000-06-19 AT AT00954149T patent/ATE527298T1/de not_active IP Right Cessation
- 2000-06-19 AU AU66484/00A patent/AU774036B2/en not_active Ceased
- 2000-06-19 KR KR1020017016230A patent/KR100701012B1/ko not_active IP Right Cessation
- 2000-06-19 WO PCT/US2000/040245 patent/WO2000078821A1/en active IP Right Grant
- 2000-06-19 IL IL14701100A patent/IL147011A0/xx active IP Right Grant
- 2000-06-19 EP EP00954149A patent/EP1200484B1/en not_active Expired - Lifetime
- 2000-06-19 CA CA002375248A patent/CA2375248C/en not_active Expired - Fee Related
-
2001
- 2001-12-10 IL IL147011A patent/IL147011A/en unknown
-
2004
- 2004-06-21 JP JP2004182917A patent/JP4727951B2/ja not_active Expired - Fee Related
-
2010
- 2010-08-26 JP JP2010190013A patent/JP2010261051A/ja active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5880231A (en) * | 1992-04-03 | 1999-03-09 | California Institute Of Technology | Synthesis of telechelic polymers using ruthenium and osmium carbene complexes |
Also Published As
Publication number | Publication date |
---|---|
IL147011A (en) | 2007-03-08 |
EP1200484B1 (en) | 2011-10-05 |
WO2000078821A1 (en) | 2000-12-28 |
AU6648400A (en) | 2001-01-09 |
ATE527298T1 (de) | 2011-10-15 |
JP2010261051A (ja) | 2010-11-18 |
MXPA01012960A (es) | 2002-07-30 |
EP1200484A1 (en) | 2002-05-02 |
JP2003502488A (ja) | 2003-01-21 |
JP2004277752A (ja) | 2004-10-07 |
JP4727951B2 (ja) | 2011-07-20 |
EP1200484A4 (en) | 2005-07-06 |
CA2375248C (en) | 2009-11-24 |
IL147011A0 (en) | 2002-08-14 |
AU774036B2 (en) | 2004-06-17 |
KR20020013585A (ko) | 2002-02-20 |
CA2375248A1 (en) | 2000-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2010261051A (ja) | 多価アレイおよび多価アレイのコンビナトリアルライブラリーを作製する方法および試薬 | |
Moses et al. | The growing applications of click chemistry | |
US6538072B2 (en) | Methods for making multivalent arrays | |
US6291616B1 (en) | Methods and reagents for capping ruthenium or osmium carbene-catalyzed ROMP products | |
Wong et al. | Orthogonality in organic, polymer, and supramolecular chemistry: from Merrifield to click chemistry | |
Binder et al. | ‘Click’chemistry in polymer and materials science | |
KR20180132501A (ko) | 초휘도 이량체성 또는 중합체성 염료 | |
US20030215801A1 (en) | Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method | |
US20030064884A1 (en) | Recyclable and reusable ruthenium catalyst for olefin metathesis | |
Tsai et al. | Vapor-based synthesis of maleimide-functionalized coating for biointerface engineering | |
Zheng et al. | Identifying the hydrolysis of carbonyl sulfide as a side reaction impeding the polymerization of N-substituted glycine N-thiocarboxyanhydride | |
US20130324738A1 (en) | Compositions and methods for making and using multifunctional polymerized liposomes | |
Tao et al. | Cationic Single-Unit Monomer Insertion (cSUMI): From Discrete Oligomers to the α-/ω-End and In-Chain Sequence-Regulated Polymers | |
Iglesias et al. | Experimental model design: exploration and optimization of customized polymerization conditions for the preparation of targeted smart materials by the Diels Alder click reaction | |
Kuciński et al. | Silica surface modification and its application in permanent link with nucleic acids | |
US20130281656A1 (en) | Methods for labeling a substrate having a plurality of thiol groups attached thereto | |
Sobieściak et al. | Double selective synthetic approach to the N-functionalized 1, 4, 7-triazacyclononane derivatives: Chelating compounds for controllable protein orientation | |
US8853132B2 (en) | Directed synthesis of oligophosphoramidate stereoisomers | |
JP4689941B2 (ja) | 固相合成担体および方法 | |
Janssen et al. | Unconventional amphiphilic polymers based on chiral polyethylene oxides | |
FR2767137A1 (fr) | Compose chimique complexe, synthese et applications diverses dudit compose | |
KR101946488B1 (ko) | 링커 화합물 및 이의 제조방법 | |
JP2003261590A (ja) | 新規なデンドリマー及びそれを用いたクラスター誘導体の合成法 | |
Schilling et al. | Synthesis and Functionalization of Biomolecules via Click Chemistry | |
Pal | Design, synthesis, and screening of a library of peptidyl bis-boroxoles as low molecular weight receptors for complex oligosaccharides in neutral water: identification of a selective receptor for the tumour marker TF-antigen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130305 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140228 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150226 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160218 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20170220 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20180219 Year of fee payment: 12 |
|
LAPS | Lapse due to unpaid annual fee |